Filter Results:
(3,166)
Show Results For
- All HBS Web
(3,166)
- People (17)
- News (870)
- Research (1,549)
- Events (20)
- Multimedia (13)
- Faculty Publications (720)
Show Results For
- All HBS Web
(3,166)
- People (17)
- News (870)
- Research (1,549)
- Events (20)
- Multimedia (13)
- Faculty Publications (720)
- August 2015 (Revised August 2015)
- Case
Hoag Orthopedic Institute
By: Robert S. Kaplan and Jonathan Warsh
Two groups of orthopedic surgeons form a joint venture with a community hospital to establish Hoag Orthopedic Institute, a for-profit hospital and two ambulatory service centers. By controlling and integrating all aspects of the patients' medical treatment, the... View Details
Keywords: Outcomes Measurement; Bundled Payment; Health Care; Activity-based Costing And Management; Measurement and Metrics; Activity Based Costing and Management; Competitive Strategy; Medical Specialties; Health Care and Treatment; Outcome or Result; Health Industry
Kaplan, Robert S., and Jonathan Warsh. "Hoag Orthopedic Institute." Harvard Business School Case 115-023, August 2015. (Revised August 2015.)
- November 2020
- Case
Wilderness Safaris: Responses to the COVID-19 Crisis
By: James E. Austin, Megan Epler Wood and Herman B. "Dutch" Leonard
This case is an epilogue to “Wilderness Safaris: Impact Investing and Ecotourism Conservation in Africa” (2-321-020), which ends with the emergence of the pandemic in March 2020. The final discussion area for that case can be “What should Wilderness Safari CEO Keith... View Details
Keywords: Communities; COVID-19; Ecotourism; Travel; Travel Industry; Conservation Planning; Reopening; Investor Relations; Project Strategy; Governance; Decision Making; Cash; Health Pandemics; Business and Shareholder Relations; Tourism Industry; Africa
Austin, James E., Megan Epler Wood, and Herman B. "Dutch" Leonard. "Wilderness Safaris: Responses to the COVID-19 Crisis." Harvard Business School Case 321-077, November 2020.
- August 2018
- Article
The Impact of the Entry of Biosimilars: Evidence from Europe
By: Fiona M. Scott Morton, Ariel Dora Stern and Scott Stern
Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby... View Details
Keywords: Health Care; Biosimilars; Biologics; Pharmaceutical Competition; Healthcare Spending; Innovation; Health Care and Treatment; Spending; Market Entry and Exit; Competition; Innovation and Invention; Pharmaceutical Industry; United States; Europe
Scott Morton, Fiona M., Ariel Dora Stern, and Scott Stern. "The Impact of the Entry of Biosimilars: Evidence from Europe." Review of Industrial Organization 53, no. 1 (August 2018): 173–210.
- October 2016
- Case
Addicaid: Scaling a Digital Platform for Addiction Wellness and Recovery
By: Robert S. Huckman and Sarah Mehta
In 2013, Sam Frons founded Addicaid—a mobile application (app) that allowed people in addiction recovery to track their progress, check in with counselors, and connect with others in recovery programs. The app was grounded in cognitive behavioral therapy and used the... View Details
Keywords: Digital Health Interventions; Substance Use Disorder; Addiction Treatment; Addiction Recovery; Scale; Innovation; Health; Health Disorders; Health Industry; New York (city, NY)
Huckman, Robert S., and Sarah Mehta. "Addicaid: Scaling a Digital Platform for Addiction Wellness and Recovery." Harvard Business School Case 617-018, October 2016.
Crystal Guo
Crystal Guo is a doctoral student in the Health Policy Management PhD program at Harvard. Prior to pursuing her PhD, Crystal received her B.A. in English and Economics from the University of California, Berkeley in 2019 and completed her Health Policy and Management,... View Details
Keywords: health care
- July 2011 (Revised June 2013)
- Case
Foxconn Technology Group (A)
By: Robert G. Eccles, George Serafeim and Beiting Cheng
In 2010, Foxconn Technology Group, the largest and fastest growing multinational company in the Electronic Manufacturing Services (EMS) industry, came under public scrutiny after a string of employee suicides reached the international press. Although the company was... View Details
Keywords: Multinational; Labor Market; Electronic Manufacturing Services; Health & Wellness; Robots; Automation; Social Responsibility; Employee Relationship Management; Leadership; Stocks; Social Issues; Corporate Social Responsibility and Impact; Capital Markets; Supply Chain Management; Safety; Environmental Accounting; Human Capital; Human Resources; Electronics Industry; Manufacturing Industry; China
Eccles, Robert G., George Serafeim, and Beiting Cheng. "Foxconn Technology Group (A)." Harvard Business School Case 112-002, July 2011. (Revised June 2013.)
- 01 Dec 2020
- News
In the Zone
When Kwame Owusu-Kesse (MBA/MPP 2012) was in his last year of graduate school, he got a call from Geoffrey Canada, founder and CEO of Harlem Children’s Zone (HCZ), a nonprofit that takes a comprehensive, cradle-to-career approach to meeting the View Details
- January 2014 (Revised March 2014)
- Teaching Note
Cancer Screening in Japan: Market Research and Segmentation
By: John A. Quelch
- March 2016
- Article
Using Quality Improvement Methods and Time-Driven Activity-Based Costing to Improve Value-Based Cancer Care Delivery at a Cancer Genetics Clinic
By: R.Y. Tan, M. Met-Domestici, K. Zhou, A.B. Guzman, S.T. Lim, K.C. Soo, T.W. Feeley and J. Ngeow
Purpose:
To meet increasing demand for cancer genetic testing and improve value-based cancer care delivery, National Cancer Centre Singapore restructured the Cancer Genetics Service in 2014. Care delivery processes were redesigned. We sought to improve access by... View Details
To meet increasing demand for cancer genetic testing and improve value-based cancer care delivery, National Cancer Centre Singapore restructured the Cancer Genetics Service in 2014. Care delivery processes were redesigned. We sought to improve access by... View Details
Keywords: Cancer Treatment; Value Based Health Care; Time-Driven Activity-Based Costing; Health Care and Treatment; Quality; Performance Improvement; Activity Based Costing and Management
Tan, R.Y., M. Met-Domestici, K. Zhou, A.B. Guzman, S.T. Lim, K.C. Soo, T.W. Feeley, and J. Ngeow. "Using Quality Improvement Methods and Time-Driven Activity-Based Costing to Improve Value-Based Cancer Care Delivery at a Cancer Genetics Clinic." Journal of Oncology Practice 12, no. 3 (March 2016): 320–331. (e-Pub 1/2016. PMID: 26759493.)
- 2019
- Working Paper
Optimal Interventions for Increasing Healthy Food Consumption Among Low Income Households
By: Retsef Levi, Elisabeth Paulson and Georgia Perakis
The federal government currently spends over $100 billion per year on policies aimed to increase fruit and vegetable (FV) consumption among low income households. These include price-, nutrition education-, and access-related interventions. Currently, the government... View Details
Keywords: Bi-level Optimization; Optimal Subsidies; Public Policy; Food Policy; Central Planner; Government Administration; Poverty; Food; Nutrition
Levi, Retsef, Elisabeth Paulson, and Georgia Perakis. "Optimal Interventions for Increasing Healthy Food Consumption Among Low Income Households." MIT Sloan Research Paper, No. 6053-19, November 2019.
- 10 Feb 2023
- Research & Ideas
COVID-19 Lessons: Social Media Can Nudge More People to Get Vaccinated
Public health officials who took to social media to push people to get the COVID-19 vaccine may have wondered if they were screaming into a void. Over the course of the pandemic, View Details
- 01 Dec 2019
- News
In My Humble Opinion: Taking Attendance
HBS, where Jones took an entrepreneurship in public education elective with Stacey Childress (MBA 2000), who now heads NewSchools Venture Fund. Childress urged her to enter the field, but Jones, intent on paying off her loans, opted for a... View Details
- 25 Jul 2023
- Research & Ideas
Could a Business Model Help Big Pharma Save Lives and Profit?
cross-sector and cross-border partnerships needed to execute the model. Adding new information about how pharmaceutical companies handle global public health challenges. Jessica Martinez, a former Big Pharma... View Details
- 14 Mar 2022
- News
Lessons from COVID-19: The Business Skills Doctors Need
Leemore S. Dafny
Leemore Dafny is the Bruce V. Rauner Professor of Business Administration and the Mary Ellen Jay and Jeffrey Jay Fellow at the Harvard Business School, and Professor of Public Policy at the Harvard Kennedy School. Dafny is an applied microeconomist whose... View Details
Keywords: health care
- 29 Oct 2020
- Research & Ideas
The COVID Gender Gap: Why Fewer Women Are Dying
According to a survey of citizens in eight countries, women are much more likely than men to view COVID-19 as a severe health problem. They are also more willing to wear face masks and follow other public... View Details
- 03 May 2022
- Cold Call Podcast
Can a Social Entrepreneur End Homelessness in the US?
Keywords: Re: Brian L. Trelstad
- 01 Mar 2013
- News
A Healthy Profit
- Research Summary
Overview
Phil's work aims to identify the drivers of performance for healthcare organizations and providers, and the mechanisms by which this performance can change over time. In complex healthcare settings, the optimal choice of treatment can be highly ambiguous. As a... View Details
Regina E. Herzlinger
Regina E. Herzlinger is the Nancy R. McPherson Professor of Business Administration at the Harvard Business School. She was the first woman to be tenured and chaired at Harvard Business School and serve on many established and start-up corporate health care/medical... View Details